Your browser doesn't support javascript.
loading
Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA.
Motiwale, Mohit; Yadav, Neetu Singh; Kumar, Sushil; Kushwaha, Tushar; Choudhir, Gourav; Sharma, Supriya; Singour, Pradeep Kumar.
Afiliação
  • Motiwale M; Computational and Synthetic Chemistry Lab, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, VNS Group of Institutions, Bhopal, India.
  • Yadav NS; Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, Delhi, New Delhi, India.
  • Kumar S; Department of Botany, Shaheed Mangal Pandey Govt. P.G. College, Madhavpurum, Meerut, India.
  • Kushwaha T; Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
  • Choudhir G; Department of Botany, CCS University, Meerut, Meerut, India.
  • Sharma S; Computational and Synthetic Chemistry Lab, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, VNS Group of Institutions, Bhopal, India.
  • Singour PK; Computational and Synthetic Chemistry Lab, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, VNS Group of Institutions, Bhopal, India.
J Biomol Struct Dyn ; 40(4): 1534-1545, 2022 03.
Article em En | MEDLINE | ID: mdl-33030102

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2022 Tipo de documento: Article